The AI Tools Speeding Up Drug Discovery Come With Risky Fine Print

Start
Every week, a lab somewhere feeds a protein sequence into AlphaFold Server and gets back a structure prediction that used to take months to solve by X-ray crystallography. Chemists run candidate molecules through Schrödinger’s software and generate leads that once required years of wet-lab screening. Universities, biotech and pharma companies now treat these and a myriad of other artificial intelligence tools as standard equipment….
By: Foley Hoag LLP
Previous Story

The AI Tools Speeding Up Drug Discovery Come With Risky Fine Print